Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

148
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
148
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

414
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
414
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

30
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
30
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

211
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
211
Dialysis01:27

Dialysis

633
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
633
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

427
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
427

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD: Case Report and Disease Update.

Diagnostics (Basel, Switzerland)·2026
Same author

Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care.

Kidney international reports·2026
Same author

Prevention of initial bone remodelling around dental implants: An international clinical consensus utilising the Delphi method.

International journal of oral implantology (Berlin, Germany)·2026
Same author

Dialysis Unit Differences in Post-Dialysis Fatigue Prevalence and Characteristics and Time to Recovery After Dialysis.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same author

Hydrothorax as a Complication of Peritoneal Dialysis: A Case Report.

Case reports in nephrology·2025
Same author

Difelikefalin for CKD-aP: real world evidence of efficacy and safety in Italian patients.

Clinical kidney journal·2025
Same journal

[Rufus of Ephesus, On gout].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

A Case Report and Literature Review: Chlorhexidine-induced anaphylaxis in a hemodialysis patient.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

New Frontiers in the Treatment of Chronic Kidney Disease-associated Pruritus: A Case of Hemoperfusion with HA130.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Fibronectin Glomerulopathy: A Case Report of Membranoproliferative Glomerulonephritis.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Sodium Disorders in Multiple Myeloma: Beyond Pseudohyponatremia to Clinical Pitfalls and Mechanistic Insights.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Acute Kidney Injury and Early Diagnostic Biomarkers: A Narrative Literature Review.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.8K

[Which future solutions for peritoneal dialysis?]

Mario Bonomini1, Lorenzo Di Liberato2, Carmela Rago3

  • 1Dipartimento di Medicina e Scienze dell'Invecchiamento, Scuola di Specializzazione in Nefrologia, Università degli Studi "G. d'Annunzio", Chieti - Pescara, Italy; UOC Clinica Nefrologica, Ospedale SS. Annunziata, Chieti, Italy.

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|October 29, 2021
PubMed
Summary
This summary is machine-generated.

New peritoneal dialysis solutions aim to improve patient outcomes by reducing the harmful effects of standard glucose-based dialysis fluids on the peritoneum. Research explores novel agents to enhance biocompatibility and long-term viability of this renal replacement therapy.

Keywords:
biocompatibilitydialysateperitoneal dialysisperitoneal dialysis solutionperitoneum

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.6K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

814

Related Experiment Videos

Last Updated: Oct 15, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.8K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.6K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

814

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Regenerative Medicine

Background:

  • Peritoneal dialysis (PD) is an effective renal replacement therapy, yet its use is limited by the bioincompatibility of conventional glucose-based solutions.
  • These solutions can induce peritoneal inflammation, fibrosis, and impaired function, potentially leading to treatment failure.

Purpose of the Study:

  • To review current and emerging strategies for enhancing the biocompatibility of peritoneal dialysis solutions.
  • To assess the clinical impact and viability of novel PD solution approaches.

Main Methods:

  • Review of literature on PD solution formulations and their effects on peritoneal membrane.
  • Analysis of strategies involving low glucose degradation products, neutral pH, icodextrin, amino acids, cytoprotective agents, and osmo-metabolic agents.
  • Evaluation of clinical outcomes and peritoneal morphology changes associated with different PD solutions.

Main Results:

  • Newer PD solutions with modified compositions show promise in mitigating peritoneal damage.
  • While some improved clinical benefits are noted, limitations and debated biocompatibility profiles persist for certain formulations.
  • Emerging strategies focus on cytoprotective and osmo-metabolic agents for further biocompatibility enhancement.

Conclusions:

  • Improving PD solution biocompatibility is crucial for enhancing patient outcomes and the long-term success of peritoneal dialysis.
  • Ongoing research into novel formulations and therapeutic agents holds potential to overcome current limitations.
  • Further investigation is needed to fully establish the clinical benefits and safety of advanced PD solutions.